The safety and efficacy of ibutilide in children and in patients with congenital heart disease

Andrew W. Hoyer, Seshadri Balaji

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Background: The safety and efficacy of ibutilide in the cardioversion of atrial flutter and atrial fibrillation in children and in patients with congenital heart disease (CHD) is unknown. Methods: Data from 19 patients (age 6 months to 34 years, median 16 years) who received ibutilide for atrial flutter or atrial fibrillation between 1996 and 2005 was retrospectively reviewed. There were 15 patients with CHD (14 had prior heart surgery); four children had normal heart structure. Results: There were 74 episodes of atrial flutter and four episodes of atrial fibrillation (median episodes per patient was one, range 1-31). Ibutilide converted 55 of all the episodes (71%). Ibutilide was successful during its first-ever administration in 12 of 19 patients (63%). Fourteen episodes in six patients required electrical cardioversion after ibutilide failed. There were no episodes of symptomatic bradycardia. One patient went into torsade de pointes and one patient had nonsustained ventricular tachycardia. Conclusion: With careful monitoring, ibutilide can be an effective tool in selected patients for cardioversion of atrial flutter.

Original languageEnglish (US)
Pages (from-to)1003-1008
Number of pages6
JournalPACE - Pacing and Clinical Electrophysiology
Volume30
Issue number8
DOIs
StatePublished - Aug 2007

Fingerprint

Heart Diseases
Safety
Atrial Flutter
Electric Countershock
Atrial Fibrillation
ibutilide
Torsades de Pointes
Bradycardia
Ventricular Tachycardia
Thoracic Surgery

Keywords

  • Antiarrhythmics
  • Arrhythmias
  • Atrial fibrillation
  • Atrial flutter
  • Children
  • Congenital heart disease

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The safety and efficacy of ibutilide in children and in patients with congenital heart disease. / Hoyer, Andrew W.; Balaji, Seshadri.

In: PACE - Pacing and Clinical Electrophysiology, Vol. 30, No. 8, 08.2007, p. 1003-1008.

Research output: Contribution to journalArticle

@article{14ba7f70c23f437b9964ecf30780b9ff,
title = "The safety and efficacy of ibutilide in children and in patients with congenital heart disease",
abstract = "Background: The safety and efficacy of ibutilide in the cardioversion of atrial flutter and atrial fibrillation in children and in patients with congenital heart disease (CHD) is unknown. Methods: Data from 19 patients (age 6 months to 34 years, median 16 years) who received ibutilide for atrial flutter or atrial fibrillation between 1996 and 2005 was retrospectively reviewed. There were 15 patients with CHD (14 had prior heart surgery); four children had normal heart structure. Results: There were 74 episodes of atrial flutter and four episodes of atrial fibrillation (median episodes per patient was one, range 1-31). Ibutilide converted 55 of all the episodes (71{\%}). Ibutilide was successful during its first-ever administration in 12 of 19 patients (63{\%}). Fourteen episodes in six patients required electrical cardioversion after ibutilide failed. There were no episodes of symptomatic bradycardia. One patient went into torsade de pointes and one patient had nonsustained ventricular tachycardia. Conclusion: With careful monitoring, ibutilide can be an effective tool in selected patients for cardioversion of atrial flutter.",
keywords = "Antiarrhythmics, Arrhythmias, Atrial fibrillation, Atrial flutter, Children, Congenital heart disease",
author = "Hoyer, {Andrew W.} and Seshadri Balaji",
year = "2007",
month = "8",
doi = "10.1111/j.1540-8159.2007.00799.x",
language = "English (US)",
volume = "30",
pages = "1003--1008",
journal = "PACE - Pacing and Clinical Electrophysiology",
issn = "0147-8389",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - The safety and efficacy of ibutilide in children and in patients with congenital heart disease

AU - Hoyer, Andrew W.

AU - Balaji, Seshadri

PY - 2007/8

Y1 - 2007/8

N2 - Background: The safety and efficacy of ibutilide in the cardioversion of atrial flutter and atrial fibrillation in children and in patients with congenital heart disease (CHD) is unknown. Methods: Data from 19 patients (age 6 months to 34 years, median 16 years) who received ibutilide for atrial flutter or atrial fibrillation between 1996 and 2005 was retrospectively reviewed. There were 15 patients with CHD (14 had prior heart surgery); four children had normal heart structure. Results: There were 74 episodes of atrial flutter and four episodes of atrial fibrillation (median episodes per patient was one, range 1-31). Ibutilide converted 55 of all the episodes (71%). Ibutilide was successful during its first-ever administration in 12 of 19 patients (63%). Fourteen episodes in six patients required electrical cardioversion after ibutilide failed. There were no episodes of symptomatic bradycardia. One patient went into torsade de pointes and one patient had nonsustained ventricular tachycardia. Conclusion: With careful monitoring, ibutilide can be an effective tool in selected patients for cardioversion of atrial flutter.

AB - Background: The safety and efficacy of ibutilide in the cardioversion of atrial flutter and atrial fibrillation in children and in patients with congenital heart disease (CHD) is unknown. Methods: Data from 19 patients (age 6 months to 34 years, median 16 years) who received ibutilide for atrial flutter or atrial fibrillation between 1996 and 2005 was retrospectively reviewed. There were 15 patients with CHD (14 had prior heart surgery); four children had normal heart structure. Results: There were 74 episodes of atrial flutter and four episodes of atrial fibrillation (median episodes per patient was one, range 1-31). Ibutilide converted 55 of all the episodes (71%). Ibutilide was successful during its first-ever administration in 12 of 19 patients (63%). Fourteen episodes in six patients required electrical cardioversion after ibutilide failed. There were no episodes of symptomatic bradycardia. One patient went into torsade de pointes and one patient had nonsustained ventricular tachycardia. Conclusion: With careful monitoring, ibutilide can be an effective tool in selected patients for cardioversion of atrial flutter.

KW - Antiarrhythmics

KW - Arrhythmias

KW - Atrial fibrillation

KW - Atrial flutter

KW - Children

KW - Congenital heart disease

UR - http://www.scopus.com/inward/record.url?scp=34547556091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547556091&partnerID=8YFLogxK

U2 - 10.1111/j.1540-8159.2007.00799.x

DO - 10.1111/j.1540-8159.2007.00799.x

M3 - Article

C2 - 17669084

AN - SCOPUS:34547556091

VL - 30

SP - 1003

EP - 1008

JO - PACE - Pacing and Clinical Electrophysiology

JF - PACE - Pacing and Clinical Electrophysiology

SN - 0147-8389

IS - 8

ER -